Skip to main
ACHC
ACHC logo

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 26 analyst ratings
Buy
Strong Buy 38%
Buy 38%
Hold 23%
Sell 0%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc is positioned favorably due to its strong performance in the behavioral health sector, marked by significant organic growth through bed expansions and new developments, alongside robust capitalization for potential mergers and acquisitions. The company anticipates substantial growth in both revenue—targeting 9-11% organic growth—and EBITDA, forecasting an increase of 10-12% from 2024 to 2028, which reflects an optimistic operational outlook. With potential improvements at underperforming facilities and a projected rise in Medicaid payments, Acadia's strategic initiatives and long-term growth targets suggest a positive trajectory for financial performance.

Bears say

Acadia Healthcare Co Inc. has faced a challenging outlook, with weaker-than-expected performance in 2024 leading to a downward revision in its 2025 guidance, resulting in EBITDA projections 10% below previous estimates. The company’s long-term margin target has also been adjusted downward, forecasting an EBITDA margin of 21.7% in 2028, a decline from 22.5% in 2024, further indicating deteriorating profitability expectations. Additionally, the enterprise multiple has contracted significantly to approximately 6.6x forward EBITDA, starkly lower than historical averages, reflecting growing investor concerns about Acadia's revenue growth and margin trajectory.

Acadia Healthcare (ACHC) has been analyzed by 26 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 38% recommend Buy, 23% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 26 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $61.10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $61.10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.